| Literature DB >> 34297973 |
Cristina Corsini Campioli1, Natalia E Castillo Almeida2, John C O'Horo3, Zerelda Esquer Garrigos4, Walter R Wilson5, Edison Cano2, Daniel C DeSimone5, Larry M Baddour5, Jamie J Van Gompel6, M Rizwan Sohail7.
Abstract
Despite advances in the diagnosis and management of brain abscess, significant associated morbidity and mortality remain high. We retrospectively reviewed adults who presented with pyogenic brain abscess from January 1, 2009, through June 30, 2020. Overall, 247 patients were identified. The median age was 59 years, and 33.6% had a history of head and neck surgery or traumatic brain injury. Diagnostic brain MRI was performed in the bulk (93.1%) of patients. Two hundred and five (83%) patients were managed with medical and surgical treatment. The most common definitive antibiotic regimen was monotherapy (48.2%). The median duration of antimicrobial therapy was 42 days. Compared to those who received combined therapy, patients with medical therapy alone had a higher mortality rate (21.4% vs. 6%; P=.003) with more neurologic sequelae (31% vs. 27.1%; P=.5). Most patients with brain abscesses are older with multiple underlying comorbidities, and one-third had antecedent head and neck surgery. A prompt combined surgical and medical approach with prolonged antimicrobial therapy may cure the infection with avoidance of permanent residual neurologic deficits.Entities:
Keywords: Brain abscess; bacterial; biopsy; cerebritis; diagnosis; immunocompromised; management; outcomes; stereotactic; surgery
Year: 2021 PMID: 34297973 DOI: 10.1016/j.amjmed.2021.05.027
Source DB: PubMed Journal: Am J Med ISSN: 0002-9343 Impact factor: 4.965